EDITH FAULKNER: Open Payments
NPI 1134460736 · STARKVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $255 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $51 |
| Incyte Corporation | 2 | $49 |
| Genmab U.S., Inc. | 2 | $40 |
| Adaptive Biotechnologies Corporation | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Geron Corporation | 1 | $19 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $18 |
Products named: KEYTRUDA, Epkinly, MONJUVI, clonoSEQ, NINLARO, JAKAFI, RYTELO, NERLYNX.
Industry payments across MS — which companies pay providers there.
